Produkty 23035-53-2

CAS 23035-53-2 występuje w naszej ofercie pod nazwami: Dydrogesterone EP Impurity A, Dydrogesterone Impurity 1（Dydrogesterone EP Impurity A）, 9β,10α-Pregna-4,6,8(14)-triene-3,20-dione, Dydrogesterone related compound A. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, Biosynth. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 2mg, 1mg.

Dydrogesterone EP Impurity A
Chemat Brand
  • opakowanie: on request
  • Warianty: 2
Zobacz produkt
Dydrogesterone Impurity 1（Dydrogesterone EP Impurity A）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
9β,10α-Pregna-4,6,8(14)-triene-3,20-dione
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
Dydrogesterone related compound A
Biosynth
  • opakowanie: 2mg, 1mg, 5mg, 10mg
  • Warianty: 4
Zobacz produkt

(9S,10S,13R,17S)-17-acetyl-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one (CAS 23035-53-2) to związek chemiczny o wzorze sumarycznym C21H26O2 i masie molowej 310.4 g/mol. Nazwa systematyczna IUPAC: (9S,10S,13R,17S)-17-acetyl-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one. InChIKey: HMDYHHQZKIYROJ-CWJKEVGVSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H26O2
Masa molowa310.4 g/mol
Nazwa IUPAC(9S,10S,13R,17S)-17-acetyl-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
InChIKeyHMDYHHQZKIYROJ-CWJKEVGVSA-N
SMILESCC(=O)[C@H]1CCC2=C3C=CC4=CC(=O)CC[C@]4([C@@H]3CC[C@]12C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 9beta,10alpha-Pregna-4,6,8(14)-triene-3,20-dione, Dydrogesterone impurity A, Dydrogesterone impurity A [EP], Dydrogesterone specified impurity A [EP], Pregna-4,6,8(14)-triene-3,20-dione, (9beta,10alpha)-, DYDROGESTERONE IMPURITY A [EP IMPURITY], DYDROGESTERONE IMPURITY A (EP IMPURITY), Dydrogesterone specified impurity A, Dydrogesterone EP Impurity A, 9|A,10|A-Pregna-4,6,8(14)-triene-3,20-dione
Izomery (ten sam wzór sumaryczny)
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one C21H26O2
4-[1-(4-hydroxyphenyl)-3,3,5-trimethylcyclohexyl]phenol C21H26O2
(1R,2R,4R,10R,11S,14S,16S,18S,19S)-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-7,15-dione C21H26O2
(8R,9S,13S,14S,17R)-17-ethynyl-4,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol C21H26O2
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C21H26O2
(8S,10S,13S,14S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,12,14,15-octahydrocyclopenta[a]phenanthren-3-one C21H26O2
(8R,9S,13S,14S,17R)-17-ethynyl-2,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol C21H26O2
(8S,9S,13S,14S,17R)-17-ethynyl-4,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-1,17-diol C21H26O2
(8R,9S,10R,13S,14S,17R)-2,2,4,6,6,10-hexadeuterio-13-ethyl-17-ethynyl-17-hydroxy-7,8,9,11,12,14-hexahydro-1H-cyclopenta[a]phenanthren-3-one C21H26O2
(8S,13S,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C21H26O2
(8R,9S,13S,14S,17R)-17-ethynyl-1,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol C21H26O2
(8R,9S,13S,14S,17R)-13-ethyl-17-ethynyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol C21H26O2